Many patients see gout as a painful but harmless joint problem. Cardiologists see it differently: gout is one of the clearest and most frequently ignored markers of cardiovascular risk.
What the data shows
Large studies across many countries consistently find gout patients have higher risk of heart attack, stroke, heart failure, atrial fibrillation and cardiovascular death. The increased risk persists after adjusting for age, smoking, blood pressure and cholesterol, meaning gout contributes something of its own. A recent gout attack is associated with a rise in heart attack and stroke risk in the weeks that follow.
Why gout harms the heart
- Inflammation: Uric acid crystals trigger inflammation not only in the joint but throughout the body. Persistent inflammation damages the inner lining of arteries and accelerates plaque formation.
- Uric acid itself: It reduces the production of nitric oxide, the substance that relaxes blood vessels, and increases oxidative stress on artery walls.
- Gout's companions: More than 70 percent of gout patients have high blood pressure. Large proportions have obesity, metabolic syndrome, high cholesterol or diabetes. Each is a major cardiac risk factor.
- Kidney disease: Gout and kidneys worsen each other, and weakened kidneys are a powerful driver of heart disease.
- Medication: NSAIDs for recurrent attacks raise blood pressure and cardiac risk when used frequently.
What this means for you
If you have gout, you should have a cardiovascular risk assessment, not just a uric acid test. That includes blood pressure, a cholesterol profile, blood sugar or HbA1c, kidney function, and an ECG. Depending on age and results, your doctor may suggest a 10-year risk calculation or a calcium score. Many patients find their gout diagnosis is the first time their high blood pressure or diabetes is detected.
Does treating gout protect the heart?
Evidence suggests yes, indirectly: controlling uric acid reduces attacks, inflammation and NSAID use. Some studies suggest allopurinol is associated with lower cardiac risk, though recent large trials have given mixed results. What is not disputed: treating blood pressure, cholesterol, sugar and weight in gout patients lowers cardiac risk substantially.
A note on febuxostat
Gout patients with existing heart disease should know that febuxostat, the alternative to allopurinol, was linked with higher cardiovascular death in one large trial. Allopurinol is usually first choice for heart patients, and febuxostat is used with caution.
The bottom line
A swollen big toe is a message from your cardiovascular system. Treat the gout, but do not stop there: check blood pressure, cholesterol, sugar and kidneys. Gout patients who do this protect far more than their joints.
What to take away
- Large studies consistently find gout patients have higher risk of heart attack, stroke, heart failure, atrial fibrillation and cardiovascular death.
- More than 70 percent of gout patients have high blood pressure, and large proportions have obesity, metabolic syndrome, high cholesterol or diabetes.
- Gout patients should have a cardiovascular risk assessment: blood pressure, a cholesterol profile, blood sugar or HbA1c, kidney function, and an ECG.

Assoc. Prof. Dr. Onn Akbar Ali
Senior Consultant Interventional Cardiologist · KPJ Ampang Puteri & KPJ Kajang Specialist Hospitals · MMC 57710 · NSR 129274
About Dr. Onn